Cadralazine

{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 443953677 | IUPAC_name = ethoxy-N'-{6-[ethyl(2-hydroxypropyl)amino]pyridazin-3-yl}carbohydrazide | image = Cadralazine Wiki Str.png

| alt2 = Cadralazine molecule

| tradename = | Drugs.com = International Drug Names | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration =

| bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion =

| CAS_number_Ref =  ^Y | CAS_number = 64241-34-5 | ATC_prefix = C02 | ATC_suffix = DB04 | PubChem = 2515 | ChEMBL_Ref =  ^N | ChEMBL = 2106561 | DrugBank_Ref =  ^Y | DrugBank = | UNII_Ref =  ^Y | UNII = 8T96I3U713 | ChemSpiderID_Ref =  ^N | ChemSpiderID = 2420 | smiles = O=C(OCC)NNc1nnc(N(CC(O)C)CC)cc1 | InChI = 1/C12H21N5O3/c1-4-17(8-9(3)18)11-7-6-10(13-15-11)14-16-12(19)20-5-2/h6-7,9,18H,4-5,8H2,1-3H3,(H,13,14)(H,16,19) | InChIKey = QLTVVOATEHFXLT-UHFFFAOYAD | StdInChI_Ref =  ^N | StdInChI = 1S/C12H21N5O3/c1-4-17(8-9(3)18)11-7-6-10(13-15-11)14-16-12(19)20-5-2/h6-7,9,18H,4-5,8H2,1-3H3,(H,13,14)(H,16,19) | StdInChIKey_Ref =  ^N | StdInChIKey = QLTVVOATEHFXLT-UHFFFAOYSA-N

| C=12 | H=21 | N=5 | O=3 | molecular_weight = 283.33 g/mol }}

WikiDoc Resources for Cadralazine
Articles
Most recent articles on Cadralazine Most cited articles on Cadralazine Review articles on Cadralazine Articles on Cadralazine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Cadralazine Images of Cadralazine Photos of Cadralazine Podcasts & MP3s on Cadralazine Videos on Cadralazine
Evidence Based Medicine
Cochrane Collaboration on Cadralazine Bandolier on Cadralazine TRIP on Cadralazine
Clinical Trials
Ongoing Trials on Cadralazine at Clinical Trials.gov Trial results on Cadralazine Clinical Trials on Cadralazine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Cadralazine NICE Guidance on Cadralazine NHS PRODIGY Guidance FDA on Cadralazine CDC on Cadralazine
Books
Books on Cadralazine
News
Cadralazine in the news Be alerted to news on Cadralazine News trends on Cadralazine
Commentary
Blogs on Cadralazine
Definitions
Definitions of Cadralazine
Patient Resources / Community
Patient resources on Cadralazine Discussion groups on Cadralazine Patient Handouts on Cadralazine Directions to Hospitals Treating Cadralazine Risk calculators and risk factors for Cadralazine
Healthcare Provider Resources
Symptoms of Cadralazine Causes & Risk Factors for Cadralazine Diagnostic studies for Cadralazine Treatment of Cadralazine
Continuing Medical Education (CME)
CME Programs on Cadralazine
International
Cadralazine en Espanol Cadralazine en Francais
Business
Cadralazine in the Marketplace Patents on Cadralazine
Experimental / Informatics
List of terms related to Cadralazine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Cadralazine is an antihypertensive of the hydrazinophthalazine chemical class.

References

Template:Nonsympatholytic vasodilatory antihypertensives Template:Hydrazines

Template:Antihypertensive-stub